Of the different insulin receptor isoforms the A isoform, which has predominant mitogenic activity, is often overexpressed in cancer cells, providing a selective growth advantage to malignant cells when exposed to insulin (Vigneri et al., 2016). The gene discussed is INSR; the disease is cancer.